This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Axonics Future Growth
Future criteria checks 4/6
Axonics is forecast to grow earnings and revenue by 50.4% and 16.5% per annum respectively. EPS is expected to grow by 51.9% per annum. Return on equity is forecast to be 4.8% in 3 years.
Key information
50.4%
Earnings growth rate
51.90%
EPS growth rate
Medical Equipment earnings growth
0%
Revenue growth rate
16.5%
Future return on equity
4.81%
Analyst coverage
Good
Last updated
21 Oct 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BMV:AXNX * - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2026
634
73
N/A
N/A
8
12/31/2025
538
43
97
N/A
11
12/31/2024
449
10
51
N/A
12
6/30/2024
409
-2
19
26
N/A
3/31/2024
387
-16
-16
-10
N/A
12/31/2023
366
-6
-6
-2
N/A
9/30/2023
343
-12
-1
2
N/A
6/30/2023
320
-32
-9
-7
N/A
3/31/2023
296
-46
9
12
N/A
12/31/2022
274
-60
1
3
N/A
9/30/2022
241
-76
-16
-13
N/A
6/30/2022
217
-77
-22
-20
N/A
3/31/2022
194
-80
-33
-31
N/A
12/31/2021
180
-80
-50
-47
N/A
9/30/2021
162
-76
-71
-69
N/A
6/30/2021
150
-68
-87
-85
N/A
3/31/2021
120
-63
-88
-86
N/A
12/31/2020
112
-55
-87
-84
N/A
9/30/2020
87
-66
-86
-84
N/A
6/30/2020
53
-82
-90
-88
N/A
3/31/2020
39
-81
-95
-94
N/A
12/31/2019
14
-80
-85
-83
N/A
9/30/2019
4
-67
-66
-65
N/A
6/30/2019
3
-49
-50
-49
N/A
3/31/2019
2
-39
-39
-38
N/A
12/31/2018
1
-32
-33
-31
N/A
9/30/2018
0
-28
-29
-27
N/A
6/30/2018
0
-25
-25
-24
N/A
3/31/2018
0
-20
N/A
-21
N/A
12/31/2017
0
-18
N/A
-18
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AXNX * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.1%).
Earnings vs Market: AXNX * is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AXNX * is expected to become profitable in the next 3 years.
Revenue vs Market: AXNX *'s revenue (16.5% per year) is forecast to grow faster than the MX market (7.1% per year).
High Growth Revenue: AXNX *'s revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AXNX *'s Return on Equity is forecast to be low in 3 years time (4.8%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/11/06 17:46
End of Day Share Price
2024/08/09 00:00
Earnings
2024/06/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Axonics, Inc. is covered by 7 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.